|
 |
doxorubicin HCl liposomeThis page contains recent news articles, when available, and an overview of doxorubicin HCl liposome but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.VELCADE plus DOXIL ® [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ... dBusinessNews Boston (press release) SILENCE THERAPEUTICS PLC - Acquisition - Dec 16, 2009 ...oncology therapeutics including Doxil(R) (doxorubicin HCL liposome injection), PegIntron(R) (Peginterferon alfa-2b) and Vectibix(R) (panitumumab). ... Trading Markets (press release) Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma - Oct 21, 2009 VELCADE plus DOXIL® [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ... Reuters Doxil (doxorubicin HCl liposome) Injection - Jan 28, 2005 New Indication: This supplemental new drug application provides for the use of Doxil (doxorubicin HCl liposome) Injection for the treatment of patients with ... Medscape DOXORUBICIN HYDROCHLORIDE LIPOSOME (Intravenous route) - dox- … - May 1, 2007 The use of doxorubicin HCl liposome injection may lead to cardiac toxicity. ... Doxorubicin HCl liposome should be administered at an initial rate of 1 ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com FDA Approvals: Doxil, Lower-Dose Duragesic, Eloxatin - Feb 10, 2005 7, the FDA granted full approval for doxorubicin HCl liposome injection (Doxil, marketed by Tibotec Therapeutics, a division of Ortho Biotech Products, ... Medscape Ortho Biotech, LP And Centocor, Inc. Alert Authorized Distributors... - May 15, 2008 Please see Important Safety Information for REMICADE(R) (infliximab), PROCRIT(R) (epoetin alfa), and DOXIL(R) (doxorubicin HCl liposome injection) at their ... RedOrbit FDA Safety Labeling Changes: Zometa, Doxil, Novamine - Mar 30, 2005 Doxorubicin HCl liposome injection is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after ... Medscape Press Release: Ortho Biotech Seeks FDA Approval for DOXIL(R) in … - Jan 22, 2007 Drug Administration (FDA) has approved Doxil(R) (doxorubicin HCl liposome injection ... treatment of refractory ovarian cancer. Doxil(R) is indicated for ... Pay-Per-View - PR Newswire - HighBeam Research Article: Doxil receives full approval.(PRODUCTS) - OB GYN News | … - Apr 1, 2005 PRODUCTS) ... find OB GYN News articles. Doxil (doxorubicin HCl liposome injection) has been granted full approval for the treatment of patients with ... Pay-Per-View - OB GYN News - HighBeam Research Women Touched By Ovarian Cancer Saluted at 'Celebrating Survivors' … - Sep 20, 2005 In the US, the company markets DOXIL(R) (doxorubicin HCl liposome injection) for the treatment of patients with ovarian cancer whose disease has progressed ... RedOrbit Interim Analysis Finds DOXIL(R)/VELCADE(R) Combination Significantly ... - Dec 11, 2006 11 /PRNewswire-FirstCall/ -- Researchers investigating the combination of DOXIL(R) (doxorubicin HCl liposome injection) and VELCADE(R) (bortezomib), ... Free with registration - PR Newswire - AccessMyLibrary.com Ortho Biotech Seeks FDA Approval For DOXIL(R) In Combination With … - Jan 23, 2007 LP, today announced that the US Food and Drug Administration (FDA) has accepted an application for DOXIL(R) (doxorubicin HCl liposome injection) as ... Medical News Today - Medical News Today (press release) US FDA Grants Full Approval To DOXIL(R) For Ovarian Cancer … - Feb 8, 2005 The US Food and Drug Administration (FDA) has granted full approval to DOXIL (doxorubicin HCl liposome injection) for the treatment of patients with ... Medical News Today - Medical News Today (press release) Press Release: Ortho Biotech Files sNDA for DOXIL(R) for the Treatment... - Sep 8, 2008 ...for the combination of DOXIL(R) (doxorubicin HCl liposome injection) and Taxotere(R) (docetaxel)* for the treatment of women with advanced breast cancer ... Pay-Per-View - PR Newswire - HighBeam Research US FDA grants full approval to DOXIL(R) for ovarian cancer progression... - Feb 9, 2005 ...(I-Newswire) - The US Food and Drug Administration ( FDA ) has granted full approval to DOXIL® ( doxorubicin HCl liposome injection ) for the treatment of ... i-newswire.com Article: Memphis, Tenn.-based drug company announces good results … - Dec 9, 2006 Ortho Biotech Products says that the US Food and Drug Administration has accepted an application for Doxil (doxorubicin HCl liposome injection) as ... Pay-Per-View - Commercial Appeal - HighBeam Research Delivering on Nano's Promise - Oct 9, 2006 In 1995, several years before the word nanotechnology began creating a buzz, Doxil (doxorubicin HCL liposome injection) received accelerated approval for ... Drug Discovery & Development FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients With ... - Jun 20, 2008 VELCADE plus DOXIL(R) [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ... RedOrbit New England Journal of Medicine Publishes Phase III Results of … - Aug 27, 2008 VELCADE plus DOXIL(R) [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ... RedOrbit Johnson & Johnson Reports Fourth-Quarter and Full-Year 2006 … - Jan 23, 2007 In addition, the Company submitted a supplemental new drug application for DOXIL (doxorubicin HCl liposome injection) as combination therapy with VELCADE ... Free with registration - PR Newswire - AccessMyLibrary.com Interim Analysis Finds DOXIL(R)/VELCADE(R) Combination Significantly ... - Dec 12, 2006 Researchers investigating the combination of DOXIL(R) (doxorubicin HCl liposome injection) and VELCADE(R) (bortezomib), the market leader in relapsed or ... Medical News Today - Medical News Today (press release) Ortho Biotech Files sNDA for DOXIL(R) for the Treatment of Advanced … - Sep 8, 2008 ...for the combination of DOXIL(R) (doxorubicin HCl liposome injection) and Taxotere(R) (docetaxel)* for the treatment of women with advanced breast cancer ... RedOrbit FDA approves VELCADE plus DOXIL combination for multiple myeloma - May 23, 2007 Ortho Biotech Products has announced the US Food and Drug Administration (FDA) has approved the use of DOXIL (doxorubicin HCl liposome injection) in ... News-Medical.net Successful Planned Independent Analysis of Pivotal Phase III Trial of... - Oct 5, 2006 The pivotal trial OVA-301 compares monotherapy CAEYLX(R) (doxorubicin HCl liposome injection), marketed as DOXIL(R) in the United States, to a combination ... ots.at FDA Safety Labeling Changes: Doxil, Concerta, and Fuzeon - Jan 12, 2005 A new boxed warning advises that myocardial damage leading to congestive heart failure may occur as the total cumulative dose of doxorubicin HCl liposome ... Medscape Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 … - Mar 10, 2008 ...with platinum-containing regimens, and fourteen of the 35 patients have also failed prior treatment with doxorubicin HCl liposome injection (Doxil®). ... Lifescience-online US FDA Approves VELCADE(R) + DOXIL(R) Combination for Treatment … - May 21, 2007 LP, today announced the US Food and Drug Administration (FDA) has approved the use of DOXIL(R) (doxorubicin HCl liposome injection) in combination with ... RedOrbit => Successful Planned Independent Analysis of Pivotal Phase III Trial... - May 10, 2006 The pivotal trial OVA-301 compares monotherapy CAEYLX(R) (doxorubicin HCl liposome injection), marketed as DOXIL(R) in the United States, to a combination ... FinanzNachrichten.de Study Finds DOXIL(R) Combination Therapy Delays Disease Progression … - Dec 14, 2008 ...and overall response rates afterreceiving a combination of DOXIL(R) (doxorubicin HCl liposome injection) anddocetaxel as compared to docetaxel alone. ... International Business Times Delivering on Nano's Promise - Oct 9, 2006 In 1995, several years before the word nanotechnology began creating a buzz, Doxil (doxorubicin HCL liposome injection) received accelerated approval for ... Nanotechnology News - Nanotechnology News (press release) Antiemetics, Their Function, and Their Role in Controlling Chemotherap... - Oct 19, 2007 Â Â Â Low-risk drugs are paclitaxel, docetaxel, mitoxantrone, topotecan, etoposide, pemetrexed, methotrexate, doxorubicin HCL liposome injection, mitomycin, ... Cancer Focus Sunesis Announces Updated Clinical Data of Voreloxin in Platinum- … - Oct 27, 2008 ...approximately one-third of the patients across the dosing cohorts have also failed prior treatment with doxorubicin HCl liposome injection (Doxil(R)). ... RedOrbit Zeltia's 2005 revenue falls 8.6% to 78.8 M euros.(Brief Article) - Mar 6, 2006 ...a Phase III study comparing Caelix/Doxil (Shering-Plough's doxorubicin HCl liposome injection) with Yondelis-Doxil combined therapy in the treatment of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Sunesis Ovarian Cancer Drug is Well-Tolerated - Oct 26, 2007 ...including the two patients with PRs, previously failed prior platinum-containing regimens and treatment with doxorubicin HCl liposome injection (Doxil). ... RedOrbit New England Journal Of Medicine Publishes Phase III Results Of … - Aug 29, 2008 VELCADE plus DOXIL(R) [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ... Medical News Today - Medical News Today (press release) New Combo Treatment for Ovarian Cancer - Nov 4, 2005 ...compared to a more typical response rate of between 12 percent and 15 percent, as seen with the drug DOXIL (doxorubicin HCl liposome injection). ... Ivanhoe Broadcast News Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing … - May 31, 2008 ...failed treatment with platinum-containing regimens, and 26 patients have also failed prior treatment with doxorubicin HCl liposome injection (Doxil(R)). ... RedOrbit Press Release: Interim Analysis Finds DOXIL(R)/VELCADE(R) … - Dec 11, 2006 11 /PRNewswire-FirstCall/ -- Researchers investigating the combination of DOXIL(R) (doxorubicin HCl liposome injection) and VELCADE(R) (bortezomib), ... Pay-Per-View - PR Newswire - HighBeam Research J&J's 4th qtr 2006 EPS beats analysts' estimate. - Jan 29, 2007 In addition, the Brunswick, New Jersey-headquartered firm submitted a supplemental New Drug Application for Doxil (doxorubicin HCl liposome injection) as ... $9.94 - Pharma Marketletter - Alacra Store The Multiple Myeloma Research Consortium Announces Initiation Of... - Aug 18, 2008 DOXIL® (doxorubicin HCl liposome injection) and dexamethasone for the treatment of multiple myeloma in patients who are previously untreated. ... Medical News Today - Medical News Today (press release) Ovarian Cancer; US FDA grants approval to ovarian cancer treatment … - Mar 7, 2005 2005 MAR 7 - (NewsRx.com & NewsRx.net) -- The US Food and Drug Administration (FDA) has granted full approval to Doxil (doxorubicin HCl liposome injection) ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Ovarian Cancer; Data monitoring committee recommends phase 3 trial of... - Oct 30, 2006 The pivotal trial OVA-301 compares monotherapy Caeylx (doxorubicin HCl liposome injection), marketed as Doxil in the United States, to a combination of ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Ortho Biotech seeks OK for Doxil/Velcade combo.(Ortho Biotech... - Jan 29, 2007 Ortho Biotech Products says that the US Food and Drug Administration has accepted an application for Doxil (doxorubicin HCl liposome injection) as ... $4.95 - Pharma Marketletter - ECNext Ovarian Cancer; US FDA grants approval to ovarian cancer treatment … - Mar 13, 2005 2005 MAR 13 - (NewsRx.com & NewsRx.net) -- The US Food and Drug Administration (FDA) has granted full approval to Doxil (doxorubicin HCl liposome injection) ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones IDMC recommends Ph III Yondelis trial continues. - Oct 16, 2006 The trial is comparing treatment with Schering-Plough's Caelyx (doxorubicin HCl liposome injection), marketed as Doxil in the USA, to a combination of that ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Sunesis Pharmaceuticals Reports Preliminary SNS-595 … - Oct 23, 2007 ...previously failed prior platinum-containing regimens and treatment with doxorubicin HCl liposome injection (Doxil(R)). Of the 2 patients with PRs, ... Pay-Per-View - PR Newswire - HighBeam Research Ovarian Cancer; US FDA grants approval to ovarian cancer treatment … - Mar 8, 2005 2005 MAR 8 - (NewsRx.com & NewsRx.net) -- The US Food and Drug Administration (FDA) has granted full approval to Doxil (doxorubicin HCl liposome injection) ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones The Multiple Myeloma Research Consortium initiates four-drug … - Aug 13, 2008 Doxil (doxorubicin HCl liposome injection) and dexamethasone for the treatment of multiple myeloma in previously untreated patients. ... $9.94 - M2 Europharma - Alacra Store Press Release: US FDA Approves VELCADE(R) + DOXIL(R) … - May 21, 2007 L.P., today announced the U.S. Food and Drug Administration (FDA) has approved the use of DOXIL(R) (doxorubicin HCl liposome injection) in combination ... Pay-Per-View - PR Newswire - HighBeam Research Accelerated US approval for Ortho Biotech's Doxil.(Ortho Biotech … - Feb 14, 2005 The US Food and Drug Adminstration has granted full approval to Doxil (doxorubicin HCl liposome injection), a treatment for ovarian cancer that has ... $4.95 - Pharma Marketletter - ECNext Press Release: Ortho Biotech, LP and Centocor, Inc. Alert Authorized ... - May 15, 2008 2008, that a transport trailer carrying DOXIL(R) (doxorubicin HCl liposome injection), PROCRIT(R) (epoetin alfa) and REMICADE(R) (infliximab) was stolen ... Pay-Per-View - PR Newswire - HighBeam Research Doxil.(Recently Approved) - Jul 1, 2007 Bridgewater, NJ-based Ortho Biotech Products LP's Doxil (doxorubicin HCl liposome injection) has been cleared for use in combination with London-based ... $4.95 - Pharmaceutical Representative - ECNext Press Release: Ortho Biotech and Amgen Resolve Antitrust Litigation. ... - Jul 11, 2008 Ortho Biotech Products says that the US Food and Drug Administration has accepted an application for Doxil (doxorubicin HCl liposome injection) as ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: US FDA Grants Full Approval to DOXIL(R) Following … - Feb 7, 2005 7 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted full approval to DOXIL(R) (doxorubicin HCl liposome injection) for the treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Sunesis Pharmaceuticals Reports Positive Interim Data ... - Mar 10, 2008 ...with platinum-containing regimens, and fourteen of the 35 patients have also failed prior treatment with doxorubicin HCl liposome injection (Doxil(R)). ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Learn How to Motivate Resistant Patients and Influence... - Oct 12, 2005 M2 Presswire; March 11, 2008 ; 700+ words ... ... failed prior treatment with doxorubicin HCl liposome injection (Doxil ). Both platinum-resistant and ... Pay-Per-View - M2 Presswire - HighBeam Research Article: Doxil receives full approval.(PRODUCTS)(Brief Article) -... - Apr 1, 2005 ...find Internal Medicine News articles. Doxil (doxorubicin HCl liposome injection) has been granted full approval for the treatment of patients with ... Pay-Per-View - Internal Medicine News - HighBeam Research Doxil receives full approval.(Products)(Brief Article) | Article from... - Jun 1, 2005 Doxil (doxorubicin HCl liposome injection) has been granted full approval for the treatment of patients with ... Pay-Per-View - Family Practice News - HighBeam Research Factiva Search - Apr 1, 2005 Doxil (doxorubicin HCl liposome injection) has been granted full approval for the treatment of patients with ovarian ... Copyright 2005 Gale Group. ... Pay-Per-View - OB GYN News - Factiva, from Dow Jones Article: No-cost anemia screening kit.(Ortho Biotech Products)(Brief... - Jun 1, 2005 Ortho Biotech Products says that the US Food and Drug Administration has accepted an application for Doxil (doxorubicin HCl liposome injection) as ... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Study Finds DOXIL(R) Combination Therapy Delays … - Dec 14, 2008 ...and overall response rates after receiving a combination of DOXIL(R) (doxorubicin HCl liposome injection) and docetaxel as compared to docetaxel alone. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Sunesis Pharmaceuticals Presents Updated Clinical Data... - May 31, 2008 ...failed treatment with platinum-containing regimens, and 26 patients have also failed prior treatment with doxorubicin HCl liposome injection (Doxil(R)). ... Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |